SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
REVENUE	$ 2,553,686			$ 2,575,086			$ 7,497,739	$ 8,089,132
COST OF REVENUE	(2,199,354)			(2,275,587)			(6,434,796)	(7,169,329)
GROSS PROFIT	354,332			299,499			1,062,943	919,803
OTHER INCOME	199,284			54,110			511,792	153,340
General and administrative							(4,426,077)	(1,241,631)
LOSS FROM OPERATIONS	(2,528,512)			(65,215)			(2,851,342)	(168,488)
FINANCE COSTS							(9,746)	(7,717)
LOSS BEFORE TAX	(2,532,771)			(67,287)			(2,861,088)	(176,205)
Tax expense							(76,418)	(22,792)
Net loss	$ (2,609,189)	$ (259,251)	$ (69,066)	$ (77,401)	$ (138,662)	$ 17,066	(2,937,506)	(198,997)
Chemrex [Member]
REVENUE							7,469,271	8,049,723
COST OF REVENUE							(6,419,947)	(7,150,156)
GROSS PROFIT							1,049,324	899,567
OTHER INCOME							507,870	146,720
General and administrative							(2,348,127)	(906,698)
LOSS FROM OPERATIONS							(790,933)	139,589
FINANCE COSTS							(6,794)	(5,521)
LOSS BEFORE TAX							(797,727)	134,068
Tax expense							(76,418)	(22,792)
Net loss							(874,145)	111,276
BGLC [Member]
REVENUE							0	0
COST OF REVENUE							0	0
GROSS PROFIT							0	0
OTHER INCOME							0	3
General and administrative							(1,907,360)	(177,247)
LOSS FROM OPERATIONS							(1,907,360)	(177,244)
FINANCE COSTS							0	0
LOSS BEFORE TAX							(1,907,360)	(177,244)
Tax expense							0	0
Net loss							(1,907,360)	(177,244)
MRRNA Scientific Malaysia [Member]
REVENUE							28,468	39,409
COST OF REVENUE							(14,849)	(19,173)
GROSS PROFIT							13,619	20,236
OTHER INCOME							3,922	6,617
General and administrative							(170,590)	(157,686)
LOSS FROM OPERATIONS							(153,049)	(130,833)
FINANCE COSTS							(2,952)	(2,196)
LOSS BEFORE TAX							(156,001)	(133,029)
Tax expense							0	0
Net loss							$ (156,001)	$ (133,029)